Teleflex Incorporated

Healthcare

NYSE:TFX · New York Stock Exchange

Market Cap $5.53B Beta 0.82 P/E (TTM) -5.5

$127.00 +0.83%

+$1.04 today

52W Low $100.18High $139.67

Vol 0.25M · Avg 0.80M

EPS (TTM) -$22.79 Div Yield 1.08%Medical - Instruments & Supplies

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+8.80%

Period High

$138.45

Period Low

$99.79

Latest

$127.00

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Arrowhead Pharmaceuticals, Inc.

NASDAQ:ARWR

$11.58B

Krystal Biotech, Inc.

NASDAQ:KRYS

$10.34B

TG Therapeutics, Inc.

NASDAQ:TGTX

$8.22B

Vaxcyte, Inc.

NASDAQ:PCVX

$7.62B

Alkermes plc

NASDAQ:ALKS

$7.55B

PTC Therapeutics, Inc.

NASDAQ:PTCT

$6.52B

Bausch + Lomb Corporation

NYSE:BLCO

$5.34B

CRISPR Therapeutics AG

NASDAQ:CRSP

$5.26B

Stevanato Group S.p.A.

NYSE:STVN

$4.86B

Merit Medical Systems, Inc.

NASDAQ:MMSI

$3.95B

What is the latest TFX filing?

The latest filing shown is 8-K dated Jun 15, 2026.

How many recent filings does TFX have?

Intrinsic Alpha currently shows 20 recent filings for TFX.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.